ATL1102

· Percheron Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATL1102, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy [Phase 2]